Dow Jones

39 671,04

0,00%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Stellar Biotechnologies, Inc. (MM) (SBOT)
Stellar Biotechnologies, Inc. (MM) (SBOT) Actualités

SBOT

Stellar Biotechnologies Inc. (SBOT)

Stellar Biotechnologies, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:SBOT

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
25/10/2019	22h16	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
25/10/2019	22h11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
13/09/2019	22h24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
13/09/2019	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
10/09/2019	12h03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
30/08/2019	22h19	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
19/08/2019	23h06	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
14/08/2019	22h20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
14/08/2019	22h13	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
11/06/2019	23h51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
07/06/2019	15h20	PR Newswire (Canada)	Edesa Biotech and Stellar Biotechnologies Complete Business Combination	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
08/05/2019	13h49	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
08/05/2019	13h45	PR Newswire (US)	Stellar Biotechnologies Reports Second Quarter Financial Results	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
18/04/2019	23h09	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
29/03/2019	21h22	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
08/03/2019	15h00	PR Newswire (Canada)	Stellar Biotechnologies and Edesa Biotech Sign Share Exchange Agreement	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
08/02/2019	19h52	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
05/02/2019	22h20	PR Newswire (US)	Stellar Biotechnologies Reports First Quarter Financial Results	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
06/12/2018	12h09	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
30/11/2018	22h34	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
30/11/2018	13h30	PR Newswire (US)	Stellar Biotechnologies Reports Fiscal Year 2018 Financial Results	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
31/10/2018	12h30	PR Newswire (US)	Stellar Biotechnologies to Present at BlueTech Summit	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
02/10/2018	22h48	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
05/09/2018	13h30	PR Newswire (US)	Stellar Biotechnologies to Supply KLH to National Institutes of Health	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
28/08/2018	13h30	PR Newswire (US)	Stellar Biotechnologies to Present at H. C. Wainwright Global Investment Conference	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
08/08/2018	13h45	PR Newswire (US)	Stellar Biotechnologies Reports Third Quarter Financial Results	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
05/07/2018	13h30	PR Newswire (US)	Stellar Issues Statement on Favorable Clinical Study Results	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
21/06/2018	13h30	PR Newswire (US)	Stellar Reports Positive Research Results from KLH Glycosylation Study	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
18/06/2018	13h18	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)
06/06/2018	12h03	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:SBOT	Stellar Biotechnologies, Inc. (MM)